# Omega-3 Hydrogel and Prevention of Oral Mucositis

> **NCT05214495** · PHASE2,PHASE3 · COMPLETED · sponsor: **Basma Morsy** · enrollment: 36 (actual)

## Conditions studied

- Mucositis Oral

## Interventions

- **DRUG:** topical oral Omega-3 hydrogel
- **DRUG:** conventional preventive treatment

## Key facts

- **NCT ID:** NCT05214495
- **Lead sponsor:** Basma Morsy
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-09
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05214495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05214495, "Omega-3 Hydrogel and Prevention of Oral Mucositis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05214495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*